• Study on Durvalumab with Chemotherapy for Patients with Advanced Biliary Tract Cancer

    Not yet recruiting

    3 1 1 1
    Investigated diseases:
    Investigated drugs:
    France Germany Italy Spain

  • Study on the Effects of XTMAB-16 and Prednisolone in Patients with Pulmonary Sarcoidosis with or without Other Body Involvement

    Not yet recruiting

    1 1 1
    Investigated diseases:
    Investigated drugs:
    Czechia Denmark Greece Italy Poland Spain

  • Montelukast Sodium for disease-modifying treatment in patients with mild‑moderate Parkinson’s disease: open‑label phase II extension study

    Not yet recruiting

    3 1 1 1
    Investigated diseases:
    Investigated drugs:
    Sweden

  • Prognostic H2[15O] PET Imaging Study in Patients with Coronary Artery Disease Using O15‑Water, Adenosine and Regadenoson

    Not yet recruiting

    3 1 1 1
    Investigated diseases:
    Investigated drugs:
    Sweden

  • Randomized Study of Tolebrutinib Versus Rituximab in Adults with Multiple Sclerosis

    Not yet recruiting

    3 1 1 1
    Investigated diseases:
    Investigated drugs:
    Sweden

  • Phase 3 Randomized Study of ALKS 2680 for Excessive Daytime Sleepiness in Adults with Narcolepsy Type 1

    Not yet recruiting

    3 1
    Investigated drugs:
    Belgium France Italy The Netherlands Spain

  • Prevention of radiation-induced salivary gland damage using botulinum toxin type A in patients with head and neck cancer

    Not yet recruiting

    2 1 1 1
    Investigated diseases:
    Investigated drugs:
    Czechia

  • Evaluation of Anifrolumab Subcutaneous Treatment in Immunosuppressant‑Naïve and Biologic‑Naïve Patients with Systemic Lupus Erythematosus

    Not yet recruiting

    3 1 1 1
    Investigated diseases:
    Investigated drugs:
    France Germany Italy Poland Spain

  • Efficacy and safety of indacaterol acetate (combined with glycopyrronium bromide and mometasone furoate) versus salmeterol/fluticasone in adolescents with asthma

    Not yet recruiting

    3 1 1
    Investigated diseases:
    Investigated drugs:
    France Germany Hungary Poland Romania Slovakia +1

  • Safety, CNS penetration and target engagement of Mirivadelgat in participants with Parkinson’s disease

    Not yet recruiting

    2 1
    Investigated diseases:
    Norway

powered by